¼¼°èÀÇ ÈÞ´ë¿ë »ê¼Ò ŰƮ ½ÃÀå
Portable Oxygen Kits
»óǰÄÚµå : 1794647
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 187 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÈÞ´ë¿ë »ê¼Ò ŰƮ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 286¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 212¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÈÞ´ë¿ë »ê¼Ò ŰƮ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 5.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 286¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÇコÄɾî ÃÖÁ¾ ¿ëµµ´Â CAGR 6.5%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 146¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °¡Á¤¿ë ÃÖÁ¾ ¿ëµµ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 2.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 58¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÈÞ´ë¿ë »ê¼Ò ŰƮ ½ÃÀåÀº 2024³â¿¡ 58¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 58¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 8.4%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 2.4%¿Í 5.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÈÞ´ë¿ë »ê¼Ò ŰƮ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾ðÁ¦ ¾îµð¼­³ª È£ÈíÀ» º¸ÀåÇÕ´Ï´Ù - ÈÞ´ë¿ë »ê¼Ò ŰƮ°¡ ÆÛ½º³ÎÄÉ¾î ¹× ÀÓ»ó Ä¡·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯

ÈÞ´ë¿ë »ê¼Ò ŰƮ°¡ ÀÇ·á ¹× ÀÀ±Þ »óȲ¿¡¼­ Á¡Á¡ ´õ Áß¿äÇØÁö´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

ÈÞ´ë¿ë »ê¼Ò ŰƮ´Â ÀÀ±Þ ÀÇ·á, ÀçÅà °£È£, °í»êÁö´ë ȯ°æ, °Ç°­ À¯Áö¿¡ ÇʼöÀûÀΠȣÈí Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ Å°Æ®¿¡´Â ÀϹÝÀûÀ¸·Î ¼ÒÇü »ê¼Ò ½Ç¸°´õ ¶Ç´Â ³óÃà±â, ºñ°­ ij´¼¶ó ¶Ç´Â ¸¶½ºÅ©, ·¹±Ö·¹ÀÌÅÍ, À¯·®°è, ÈÞ´ë¿ë °¡¹æ ¶Ç´Â Æ®·Ñ¸®°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. À̵¿¼º°ú »ç¿ë ÆíÀǼºÀ» °í·ÁÇÏ¿© ¼³°èµÈ ÈÞ´ë¿ë »ê¼Ò ½Ã½ºÅÛÀº ȯÀÚ¿Í »ç¿ëÀÚ°¡ Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» À¯ÁöÇϸ鼭 Ä¡·á¿ë »ê¼Ò¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù.

COPD, õ½Ä, COVID-19 ÈÄÀ¯Áõ, Æó¼¶À¯Áõ µî È£Èí±âÁúȯ¿¡ ´ëÇÑ Àü ¼¼°è ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÈÞ´ë¿ë »ê¼Ò °ø±Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àå±â »ê¼Ò ¿ä¹ý(LTOT)ÀÌ ÇÊ¿äÇÑ È¯ÀÚµéÀº ÇöÀç °æ·® ±¸Á¶, Á¶¿ëÇÑ ÀÛµ¿, Á¶Àý °¡´ÉÇÑ À¯·®, ¹èÅ͸® ±¸µ¿ ¶Ç´Â ¸®ÇÊ ±â´ÉÀ» Á¦°øÇÏ´Â ÀåÄ¡¸¦ ¼±È£Çϰí ÀÖ½À´Ï´Ù.

°øÁß º¸°Ç¿¡ ´ëÇÑ ÀνÄ, ºñ»ó»çÅ ´ëºñ Ä·ÆäÀÎ, ÀçÅà °£È£¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÈÞ´ë¿ë ŰƮÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ÀÓ»ó ȸº¹»Ó¸¸ ¾Æ´Ï¶ó ¿©Çà, °í°ø °ü±¤, Àç³­ ±¸Á¶, ÀÀ±Þ óġ¿¡µµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, Çö´ë È£Èí±â °Ç°­ °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

¾î¶² ÃÖÁ¾»ç¿ëÀÚ ºÎ¹®°ú ¹èÆ÷ ¼³Á¤ÀÌ ½ÃÀå Ȱ¿ëÀ» ÃËÁøÇϴ°¡?

ȨÄɾî´Â ÈÞ´ë¿ë »ê¼Ò ŰƮÀÇ °¡Àå Áß¿äÇÑ ÀÀ¿ë ºÐ¾ßÀÔ´Ï´Ù. ¸¸¼º È£Èí±âÁúȯ ȯÀÚµéÀº ÀÔ¿ø, À̵¿ÀÇ Á¦¾à, ÀÇ·áºñ Àý°¨ µîÀÇ ÀÌÀ¯·Î ÀçÅà ġ·á¸¦ Á¡Á¡ ´õ ¼±È£Çϰí ÀÖ½À´Ï´Ù. ÃæÀü½Ä ¹èÅ͸®¿Í °æ·® ½Ç¸°´õ°¡ ÀåÂøµÈ ÈÞ´ë¿ë »ê¼Ò¹ß»ý±â(POC)´Â °í·ÉÀÚ³ª °Åµ¿ÀÌ ºÒÆíÇÑ È¯ÀÚµéÀÇ µ¶¸³¼ºÀ» ³ô¿©ÁÝ´Ï´Ù.

º´¿ø, ¿ä¾ç½Ã¼³, ¿Ü·¡ Áø·á¼Ò¿¡¼­´Â ¼ö¼ú ÈÄ È¸º¹, Àüȯ±â °ü¸®, º´¿ø ³» À̵¿ ½Ã »ê¼Ò Åõ¿©¸¦ Áö¿øÇϱâ À§ÇØ ÈÞ´ë¿ë ŰƮ¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÀ±ÞÀÇ·á¼­ºñ½º(EMS), ±¸±ÞÂ÷, ±¸±Þ´ë¿øµéÀº ƯÈ÷ ¿Ü»ó, ½ÉÀ帶ºñ, È£ÈíºÎÀü ½Ã³ª¸®¿À¿¡¼­ »ê¼Ò ŰƮ¸¦ º´¿ø Àü ÀÀ±ÞóġÀÇ ÇÙ½É ¿ä¼Ò·Î Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù.

±º»ç, Ç×°ø, µî»ê ºÐ¾ß¿¡¼­´Â °í°ø ÀÛ¾÷À̳ª ±ØÇÑÀÇ À°Ã¼³ëµ¿ ½Ã Àú»ê¼ÒÁõ ´ëÃ¥À¸·Î °í¼øµµ ÈÞ´ë¿ë »ê¼Ò ŰƮ¸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ¸ðÇèÀ» Áñ±â´Â ¿©ÇàÀÚ³ª ÇÇÆ®´Ï½º ¾ÖÈ£°¡µéÀº °í»êÁö´ë¿¡¼­ ªÀº ½Ã°£ µ¿¾È »ê¼Ò¸¦ ÈíÀÔÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ¼ÒÇü ÀÏȸ¿ë »ê¼Ò ½Ç¸°´õ¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ÀϺΠÀ£´Ï½º ½ÃÀå¿¡¼­´Â ¾ÆÁ÷ ÀÇÇÐÀû °ËÁõÀÌ Á¦ÇÑÀûÀÌÁö¸¸, ·¹Å©¸®¿¡ÀÌ¼Ç¿ë »ê¼Ò ¿ä¹ýÀÌ Æ®·»µå·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ±¤»ê, È­ÇаøÀå, ¹ÐÆóµÈ °ø°£ µî À§ÇèÇÑ È¯°æ¿¡ ÀÖ´Â ÀÛ¾÷Àå¿¡¼­ÀÇ ¼ö¿äµµ Áõ°¡Çϰí ÀÖÀ¸¸ç, ºñ»ó½Ã ½Å¼ÓÇÑ »ê¼Ò °ø±ÞÀÌ Àǹ«È­µÇ¾î ÀÖ½À´Ï´Ù. °øÇ×, °æ±âÀå, ¼îÇθô µî¿¡¼­´Â °©ÀÛ½º·¯¿î È£Èí±â »ç°í¿¡ ´ëÀÀÇϱâ À§ÇØ AED¿Í °°Àº °ø°ø Á¢±Ù ŰƮ¸¦ ¹èÄ¡Çϰí ÀÖ½À´Ï´Ù.

±â¼ú, È޴뼺, ¾ÈÀü¼ºÀÇ Çõ½ÅÀº Á¦Ç° µðÀÚÀÎÀ» ¾î¶»°Ô °­È­Çϴ°¡?

ÃֽŠÈÞ´ë¿ë »ê¼Ò ŰƮ´Â ´Ù¾çÇÑ »ç¿ëÀÚ ±×·ìÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ Ã·´Ü ±â¼úÀ» µµÀÔÇß½À´Ï´Ù. ¾Ð·Â ½ºÀ® ÈíÂø(PSA) ½Ã½ºÅÛÀ» °®Ãá POC´Â ÁÖº¯ °ø±â¿¡¼­ »ê¼Ò¸¦ ³óÃàÇÏ¿© ½Ç¸°´õ¸¦ º¸ÃæÇÒ Çʿ䰡 ¾ø½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡¿¡´Â Á¾Á¾ ´ÙÁß À¯·® ¼³Á¤(ÆÞ½º Åõ¿© ¶Ç´Â ¿¬¼Ó À¯·®), Àå¼ö¸í ¹èÅ͸®(ÃÖ´ë 12½Ã°£), ÃæÀüÀÇ À¯¿¬¼ºÀ» ³ôÀ̱â À§ÇÑ Â÷·®¿ë/°¡Á¤¿ë ¾î´ðÅͰ¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»ê¼Ò ½Ç¸°´õ´Â ±âÁ¸ÀÇ °­Ã¶ ´ë½Å º¹ÇÕ Åº¼Ò¼¶À¯ ¼ÒÀ縦 »ç¿ëÇÏ¿© °æ·®È­ÇÏ¿© ¿î¹ÝÀÇ ºÎ´ãÀ» ÁÙ¿´½À´Ï´Ù. ³»ÀåµÈ µðÁöÅÐ À¯·®°è¿Í »ê¼Ò ¼¾¼­´Â ½Ç½Ã°£ ³óµµ ¸ð´ÏÅ͸µ, Àú¼øµµ ¹× Àú¾Ð °æº¸, »ç¿ë·® ÃßÀûÀ» Á¦°øÇÕ´Ï´Ù. ÀÎü°øÇÐÀû ¸¶½ºÅ©¿Í ºÎµå·¯¿î ÄÚ Ä³´¼¶ó´Â Àå½Ã°£ »ç¿ë ½Ã Æí¾ÈÇÔÀ» Çâ»ó½Ãŵ´Ï´Ù.

Á¦Á¶¾÷ü´Â °£º´ÀÎÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ°ú °Ç°­ ¾Û ¹× ¿ø°ÝÀÇ·á Ç÷§Æû°úÀÇ ÅëÇÕÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ºí·çÅõ½º ¿¬°áÀ» ³»ÀåÇϰí ÀÖ½À´Ï´Ù. ÅÍÄ¡½ºÅ©¸° ÀÎÅÍÆäÀ̽º, À½¼º ¾È³», ´Ù±¹¾î ¼³Á¤À¸·Î Á¢±Ù¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ÀÚµ¿ °íµµ Á¶Àý, ¿Âµµ ȸº¹·Â, Àú¼ÒÀ½ ¼º´ÉÀº ¸ð¹ÙÀÏ »ç¿ëÀÚ¿¡°Ô ƯÈ÷ °¡Ä¡°¡ ÀÖ½À´Ï´Ù.

¾ÈÀü ±â´ÉÀ¸·Î´Â ¾Ð·Â ¸±¸®ÇÁ ¹ëºê, ³»È­¼º ¼ÒÀç, º¯Á¶ ¹æÁö ·¹±Ö·¹ÀÌÅÍ µîÀÌ ÀÖ½À´Ï´Ù. ÀÇ·á¿ë »ê¼ÒÀÇ Ç°Áú°ú ISO/CE/FDA ÀÎÁõÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ÀÓ»óÀû ¼ö¿ë°ú Á¶´Þ¿¡ °è¼Ó Áß¿äÇÏ°Ô ÀÛ¿ëÇÕ´Ï´Ù.

ÈÞ´ë¿ë »ê¼Ò ¿ä¹ý ¼¼°è ½ÃÀå µ¿Çâ°ú ¼ºÀå µ¿·ÂÀº ¹«¾ùÀΰ¡?

ÈÞ´ë¿ë »ê¼Ò ŰƮ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¸¸¼º È£Èí±âÁúȯÀÇ Áõ°¡, ÀçÅÃÀÇ·á ¹× ºÐ»êÇü ÀÇ·á·ÎÀÇ Àüȯ, ºñ»ó»çÅ ´ëºñ¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡ÀÔ´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎÀº Àú»ê¼ÒÁõ°ú È£Èí°ï¶õ¿¡ °¡Àå Ãë¾àÇÑ °èÃþÀ» ´ëÇ¥ÇÏ´Â ³ë·ÉÀα¸ÀÇ È®´ëÀÔ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î Æò±Õ ¼ö¸íÀÌ ´Ã¾î³²¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ´Â À̵¿½Ä »ê¼Ò ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿äµµ ±×¿¡ µû¶ó È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀº È£Èí±â À§±â¿¡¼­ ÈÞ´ë¿ë »ê¼ÒÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ºÎ°¢½ÃÄ×½À´Ï´Ù. »ê¼Ò ºÎÁ·°ú º´¿ø °ú¹ÐÈ­·Î ÀÎÇØ ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ ºÎÁ·ÇÑ ½ÅÈï ½ÃÀå¿¡¼­ °¡Á¤¿ë ³óÃà±â ¹× ¸®ÇÊ Å°Æ®¿¡ ´ëÇÑ Àü ¼¼°è ÅõÀÚ°¡ °¡¼ÓÈ­µÇ¾ú½À´Ï´Ù. ÀÌ ½Ã±â¿¡´Â °¡Á¤¿ë È£Èí º¸Á¶ ½Ã½ºÅÛÀÇ Çʿ伺¿¡ ´ëÇÑ ÀϹÝÀεéÀÇ Àνĵµ ³ô¾ÆÁ³½À´Ï´Ù.

¿Ü·¡ Áø·á, ¿ø°Ý ¸ð´ÏÅ͸µ, ȯÀÚ ÀÚ°¡ °ü¸® µî ÇコÄÉ¾î ½Ã½ºÅÛÀÇ À籸ÃàÀÌ ¼ö¿ä¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ¸¹Àº ³ª¶ó¿¡¼­ º¸Çè ȯ±Þ Á¤Ã¥ÀÌ Àû¿ëµÇ°í ÀÖÀ¸¸ç, ÀÚ°ÝÀ» °®Ãá ȯÀÚ¿¡°Ô POC ±â±â°¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç×°ø»ç¿Í ±³Åë±â°üÀÌ ÀÇ·á±â±âÀÇ ¿î¼ÛÀ» Áö¿øÇÔ¿¡ µû¶ó ¿©Çà ±ÔÁ¤ÀÌ ÈÞ´ë¿ë »ê¼Ò »ç¿ëÀÚ¿¡ ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï º¯È­Çϰí ÀÖ½À´Ï´Ù.

½º¸¶Æ® °Ç°­ ±â¼ú, ¸ðºô¸®Æ¼ Çõ½Å, ¸¸¼ºÁúȯ °ü¸®ÀÇ À¶ÇÕÀ¸·Î ÈÞ´ë¿ë »ê¼Ò ŰƮ´Â ÀÀ±Þ Àåºñ¿¡¼­ ÁÖ·ù È£Èí º¸Á¶ ÀåÄ¡·Î º¯¸ðÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

ºÎ¹®

ÃÖÁ¾ ¿ëµµ(ÇコÄɾî, °¡Á¤ ¿ëµµ, Ç×°ø¿ìÁÖ¡¤ÀÚµ¿Â÷, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°è °íÀ¯ÀÇ SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Portable Oxygen Kits Market to Reach US$28.6 Billion by 2030

The global market for Portable Oxygen Kits estimated at US$21.2 Billion in the year 2024, is expected to reach US$28.6 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.6 Billion by the end of the analysis period. Growth in the Home Application End-Use segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.8 Billion While China is Forecast to Grow at 8.4% CAGR

The Portable Oxygen Kits market in the U.S. is estimated at US$5.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.8 Billion by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Portable Oxygen Kits Market - Key Trends & Drivers Summarized

Breathing Assurance Anytime, Anywhere: Why Portable Oxygen Kits Are Vital in Personal and Clinical Care Settings

Why Are Portable Oxygen Kits Gaining Critical Importance in Medical and Emergency Scenarios?

Portable oxygen kits provide essential respiratory support in medical emergencies, homecare settings, high-altitude environments, and wellness routines. These kits typically include a compact oxygen cylinder or concentrator, nasal cannula or mask, regulator, flowmeter, and carrying bag or trolley. Designed for mobility and ease of use, portable oxygen systems allow patients and users to access therapeutic oxygen while maintaining an active lifestyle.

The rising global burden of respiratory illnesses-including COPD, asthma, COVID-19 sequelae, and pulmonary fibrosis-has significantly increased the demand for portable oxygen delivery systems. Patients who require long-term oxygen therapy (LTOT) now prioritize units that offer lightweight construction, quiet operation, adjustable flow rates, and battery-powered or refillable functionality.

Public health awareness, emergency preparedness campaigns, and the growing demand for home-based care have catalyzed the uptake of portable kits. These devices serve a crucial role not only in clinical recovery but also in travel, high-altitude tourism, disaster relief, and first aid-making them an integral part of modern respiratory healthcare.

Which End-User Segments and Deployment Settings Are Driving Market Utilization?

Homecare represents the most significant application segment for portable oxygen kits. Patients with chronic respiratory conditions increasingly prefer in-home therapy to reduce hospitalization, travel constraints, and healthcare costs. Portable oxygen concentrators (POCs) with rechargeable batteries and lightweight cylinders are enabling greater independence among elderly and mobility-restricted patients.

Hospitals, nursing homes, and outpatient clinics use portable kits to support post-surgical recovery, transitional care, and oxygen administration during intra-hospital transfers. Emergency medical services (EMS), ambulances, and paramedics depend on oxygen kits as a core component of pre-hospital care-particularly in trauma, cardiac arrest, or respiratory failure scenarios.

Military, aviation, and mountaineering sectors utilize high-purity portable oxygen kits to combat hypoxia during high-altitude operations or extreme physical exertion. Adventure travelers and fitness enthusiasts use smaller, disposable oxygen canisters for short bursts of relief in high-elevation zones. In some wellness markets, recreational oxygen therapy is emerging as a trend, although medical validation is still limited.

Demand is also rising from workplaces in hazardous environments-such as mining, chemical plants, and confined spaces-where rapid oxygen access is mandated for emergency preparedness. Public access kits are being deployed in airports, stadiums, and shopping malls, much like AEDs, to respond to sudden respiratory incidents.

How Are Technology, Portability, and Safety Innovations Enhancing Product Design?

Modern portable oxygen kits are incorporating advanced technologies to meet the needs of diverse user groups. POCs with pressure swing adsorption (PSA) systems concentrate oxygen from ambient air, eliminating the need for cylinder refills. These devices often include multiple flow settings (pulse-dose or continuous flow), long-life batteries (up to 12 hours), and car/home adapters for recharging flexibility.

Oxygen cylinders are becoming lighter through the use of composite carbon fiber materials, replacing traditional steel to reduce carry burden. Integrated digital flowmeters and oxygen sensors provide real-time concentration monitoring, alarms for low purity or pressure, and usage tracking. Ergonomic masks and soft nasal cannulas improve comfort during extended use.

Manufacturers are embedding Bluetooth connectivity to allow remote monitoring by caregivers and integration with health apps or telemedicine platforms. Touchscreen interfaces, voice prompts, and multilingual settings are enhancing accessibility. Automatic altitude adjustment, temperature resilience, and low-noise performance are particularly valuable for mobile users.

Safety features include pressure relief valves, fire-resistant materials, and tamper-proof regulators. Medical-grade oxygen quality and ISO/CE/FDA certifications remain critical for clinical acceptance and procurement by healthcare providers.

What Market Trends and Drivers Are Supporting Global Growth in Portable Oxygen Therapy?

The growth in the portable oxygen kits market is driven by the rise in chronic respiratory conditions, the shift toward home-based and decentralized care, and increased awareness around emergency preparedness. A primary driver is the expanding geriatric population, which represents the most vulnerable demographic for hypoxia and respiratory distress. As life expectancy increases globally, demand for reliable, mobile oxygen therapy will scale accordingly.

The COVID-19 pandemic highlighted the critical role of portable oxygen during respiratory crises. Oxygen shortages and hospital overcrowding accelerated global investment in home concentrators and refillable kits-especially in emerging markets with constrained medical infrastructure. This period also raised public awareness of the need for at-home respiratory support systems.

Healthcare system restructuring-favoring outpatient care, remote monitoring, and patient self-management-is reinforcing demand. Reimbursement policies are adapting in many countries to cover POC devices for eligible patients. Moreover, travel regulations are increasingly accommodating portable oxygen users, with airlines and transit systems supporting medical equipment carriage.

The convergence of smart health technologies, mobility innovations, and chronic disease management is likely to transform portable oxygen kits from emergency tools into mainstream respiratory support devices-extending care boundaries and enabling life-sustaining freedom for millions of users worldwide.

SCOPE OF STUDY:

The report analyzes the Portable Oxygen Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Healthcare End-Use, Home Application End-Use, Aerospace & Automotive End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â